Raltitrexed (Tomudex) versus standard leucovorin-modulated bolus 5-fluorouracil: Results from the randomised phase III Pan-European Trial in Adjuvant Colon Cancer 01 (PETACC-1). [electronic resource]
Producer: 20081210Description: 2204-11 p. digitalISSN:- 1879-0852
- Adult
- Aged
- Aged, 80 and over
- Antimetabolites, Antineoplastic -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Chemotherapy, Adjuvant
- Colonic Neoplasms -- drug therapy
- Female
- Fluorouracil -- administration & dosage
- Humans
- Leucovorin -- administration & dosage
- Male
- Middle Aged
- Quinazolines -- adverse effects
- Survival Analysis
- Thiophenes -- adverse effects
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.